These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient. Krystal AD, Watts BV, Weiner RD, Moore S, Steffens DC, Lindahl V. J ECT; 1998 Mar; 14(1):5-14. PubMed ID: 9661088 [Abstract] [Full Text] [Related]
11. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine. Addolorato G, Balducci G, Capristo E, Attilia ML, Taggi F, Gasbarrini G, Ceccanti M. Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990 [Abstract] [Full Text] [Related]
12. Effects of nitrendipine, chlordiazepoxide, flumazenil and baclofen on the increased anxiety resulting from alcohol withdrawal. File SE, Zharkovsky A, Hitchcott PK. Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jan; 16(1):87-93. PubMed ID: 1557510 [Abstract] [Full Text] [Related]
13. The anxiolytic etifoxine protects against convulsant and anxiogenic aspects of the alcohol withdrawal syndrome in mice. Verleye M, Heulard I, Gillardin JM. Alcohol; 2009 May; 43(3):197-206. PubMed ID: 19393860 [Abstract] [Full Text] [Related]